DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis

Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma

(2017) Yan Yang et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma

(2017) Xuefei Feng et al.   Oncotarget

WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma

(2016) Zeinab Ahsani et al.   APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling

(2016) JIN-YAN ZHANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

DEP Domain Containing 1 is a Novel Diagnostic Marker and Prognostic Predictor for Hepatocellular Carcinoma

(2015) Sheng-Guang Yuan et al.   Asian Pacific Journal of Cancer Prevention

Changing epidemiology of hepatocellular carcinoma in Asia

(2015) George Boon-Bee Goh et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells

(2015) Xiaoqin Wu et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells

(2014) Ming-Ju Hsieh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma

(2013) Ruchi Shukla et al.   CELL

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells

(2013) Alboukadel Kassambara et al.   PLoS One

Making sense of cancer genomic data

(2011) Lynda Chin et al.   GENES & DEVELOPMENT

Cancer genomics: from discovery science to personalized medicine

(2011) Lynda Chin et al.   NATURE MEDICINE

Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells

(2010) Y. Harada et al.   CANCER RESEARCH

A census of human transcription factors: function, expression and evolution

(2009) Juan M. Vaquerizas et al.   NATURE REVIEWS GENETICS